ANROVSBTAI• 6 Months (Normalized)
ANRO vs BTAI (Alto Neuroscience Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
BTAI Performance $0.04
-96.9%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+96.9 pts
ANRO outperforming by 96.90 percentage points
ANROBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(120 dates)
| Date | ANRO Price | ANRO Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $- | $0.04 | -96.90% | - | |
| Sep 23, 2026 | $27.50 | +22.06% | $0.05 | -96.05% | +118.11% |
| Sep 22, 2026 | $30.78 | +36.62% | $0.04 | -96.09% | +132.71% |
| Sep 21, 2026 | $30.63 | +35.95% | $0.06 | -94.61% | +130.56% |
| Sep 18, 2026 | $30.27 | +34.35% | $0.06 | -94.91% | +129.26% |
| Sep 17, 2026 | $30.98 | +37.51% | $0.08 | -93.41% | +130.92% |
| Sep 16, 2026 | $30.00 | +33.16% | $0.07 | -94.13% | +127.29% |
| Sep 15, 2026 | $30.25 | +34.27% | $0.04 | -96.08% | +130.35% |
| Sep 14, 2026 | $31.68 | +40.61% | $0.05 | -96.04% | +136.65% |
| Sep 11, 2026 | $32.00 | +42.03% | $0.05 | -95.53% | +137.56% |
| Sep 10, 2026 | $31.68 | +40.61% | $0.05 | -95.61% | +136.22% |
| Sep 09, 2026 | $34.07 | +51.22% | $0.05 | -95.88% | +147.10% |
| Sep 08, 2026 | $35.81 | +58.94% | $0.04 | -96.23% | +155.17% |
| Sep 04, 2026 | $35.55 | +57.79% | $0.07 | -93.52% | +151.31% |
| Sep 03, 2026 | $36.40 | +61.56% | $0.12 | -89.65% | +151.21% |
Page 1 of 8